Safety and Efficacy of CD37-Targeting Naratuximab Emtansine PLUS Rituximab in Diffuse Large B-Cell Lymphoma and Other NON-Hodgkin'S B-Cell Lymphomas - a Phase 2 Study
Levy, Moshe Y., Jagadeesh, Deepa, Grudeva-Popova, Zhanet, Trněný, Marek, Jurczak, Wojciech, Pylypenko, Halyna, André, Marc, Dwivedy Nasta, Sunita, Rechavi-Robinson, Dalit, Toffanin, Sara, Micallef, Sandrine, Attinger, Antoine, Rouits, Elisabeth, Roubaudi-Fraschini, Marie-Claude, Orfanos, Panos, Dymkowska, Mariola, Nauwelaerts, Heidi, Woei-a-Jin, Sherida
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Abstract 5001: Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients with resectable squamous cell carcinoma of the head and neck
Gomez-Roca, Carlos, Even, Caroline, Tourneau, Christophe Le, Rotllan, Neus Basté, Delord, Jean-Pierre, Sarini, Jerome, Vergez, Sebastien, Teman, Stephane, Hoffmann, Caroline, Rochaix, Philippe, Gavillet, Bruno, Rouits, Elisabeth, Brichory, Franck, Rechavi-Robinson, Dalit, Bize, Vincent, Rizzo, Sebastien Del, Purcea, Daniela, Brienza, Silvano, Zanna, Claudio, Vuagniaux, Gregoire, Szyldergemajn, Sergio
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article